Drugs / Jinhua Qinggan (JHQG) Granules
Jinhua Qinggan (JHQG) Granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04723524 | Sep 2020 → Aug 2021 | COVID-19 | University of Karachi | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jinhua Qinggan (JHQG) Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04723524 ↗ |
| Known as | JHQG | “The efficacy of Jinhua Qinggan granules (JHQG) in COVID-19 patients with mild symptoms has yet to be clearly defined.” PMID 35979216 ↗ Aug 2022 |
| Known as | Jinhua Qinggan granules | “The efficacy of Jinhua Qinggan granules (JHQG) in COVID-19 patients with mild symptoms has yet to be clearly defined.” PMID 35979216 ↗ Aug 2022 |
| Modality | Traditional medicine (herbal / TCM) | “Jinhua Qinggan (JHQG) Granules, Traditional Chinese Medicine” NCT04723524 ↗ |
| Route | Oral | “Participants were randomly assigned to receive 5 g/sacket of JHQG or placebo granules orally thrice daily for 10 days.” PMID 35979216 ↗ Aug 2022 |